Blood test for various helminths: The most common is the IgG blood test, which can show that your child has had contact with a certain helminth at some point. However, it does not indicate if the ...

Usually, this type of treatment is used for populations at risk of contracting human helminth diseases. In this instance, it seems like Princess Kate might be referring more to something called ...

Following Priority Review, Dupixent is now available to patients as young as 12 years with inadequately controlled CRSwNPCurrent treatment ...

AstraZeneca’s FASENRA ® (benralizumab) has been approved in the US for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). 1 EGPA is a rare, immune-mediated ...

Government, stakeholders and the citizens have been charged to join hands and step up efforts at ending open defecation and ...

Such symptoms might be due to urticaria, commonly known as hives. Urticaria is a skin condition characterised by red, itchy welts. Although the itchiness might be temporary, the condition can recur, ...

Lilly has exclusive rights for development and commercialization of EBGLYSS in the U.S. and the rest of the world outside Europe. Lilly's partner Almirall S.A. has licensed the rights to develop and ...

Recommendation based on a Phase 3 trial showing a significantly greater proportion of children on Dupixent achieved histological remission ...

近日，Immunity杂志背靠背发表华盛顿医学院Tyler E. Billipp研究团队题为Tuft cell-derived acetylcholine promotes epithelial chloride secretion and intestinal helminth clearance的研究文章和法国蒙彼利埃大学功能基因研究 ...

Eli Lilly and Company (NYSE: LLY) announced today the U.S. Food and Drug Administration (FDA) approved EBGLYSS™ (lebrikizumab-lbkz), a targeted IL-13 inhibitor, for the treatment of adults and ...